| | |
| Clinical data | |
|---|---|
| Other names | L-2-Amino-4-phosphonobutyric acid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.164.384 |
| Chemical and physical data | |
| Formula | C4H10NO5P |
| Molar mass | 183.100 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
L-AP4 (L-2-amino-4-phosphonobutyric acid) is a drug used in scientific research, which acts as a group-selective agonist for the group III metabotropic glutamate receptors (mGluR4 / 6 / 7 / 8). It was the first ligand found to act as an agonist selective for this group of mGlu receptors, [1] but does not show selectivity between the different mGluR Group III subtypes. It is widely used in the study of this receptor family and their various functions. [2] [3] [4] [5]